August 2023 Price Concessions Final Update
THIS CONTENT HAS NOW EXPIRED
Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (30/08/2023) announced the following final list of price concessions for August 2023.
Our Funding and Reimbursement Team will be hosting a webinar on price concessions on the evening of 5th September 2023 to help to explain how the concessions system works and what happens when pharmacy owners report increased prices to us. Some of our Committee Members will also be on hand to talk about our calls for improvements in the system, answer your questions and hear further feedback for DHSC. Book your place now (note, registration will close at 3pm on the day of the event).
*This price concession was withdrawn following a price adjustment under the price change mechanism. The new reimbursement price for August 2023 is £29.94. Click here for more information.
| Drug | Pack size | Price concession |
| Amisulpride 200mg tablets | 60 | £32.34 |
| Atomoxetine 10mg capsules | 28 | £36.44 |
| Atomoxetine 25mg capsules | 28 | £31.95 |
| Atomoxetine 60mg capsules | 28 | £48.64 |
| Atorvastatin 80mg tablets | 28 | £5.26 |
| Betahistine 8mg tablets | 84 | £3.89 |
| Betamethasone valerate 0.1% cream | 30 | £4.49 |
| Brimonidine 0.2% eye drops | 5 | £2.36 |
| Chlorphenamine 2mg/5ml oral solution sugar free | 150 | £7.39 |
| Cinacalcet 30mg tablets | 28 | £7.49 |
| Clarithromycin 500mg tablets | 14 | £7.69 |
| Clonazepam 500microgram tablets | 100 | £23.94 |
| Dorzolamide 20mg/ml / Timolol 5mg/ml eye drops | 5 | £2.69 |
| Eplerenone 50mg tablets | 28 | £5.89 |
| Etoricoxib 60mg tablets | 28 | £2.27 |
| Flucloxacillin 250mg/5ml oral solution | 100 | £3.35 |
| Fludrocortisone 100microgram tablets | 30 | £7.05 |
| Itraconazole 100mg capsules | 15 | £9.48 |
| Latanoprost 50micrograms/ml / Timolol 5mg/ml eye drops | 2.5 | £11.28 |
| Letrozole 2.5mg tablets | 14 | £4.62 |
| Orlistat 120mg capsules | 84 | £24.74 |
| Permethrin 5% cream | 30 | £11.99 |
| Phenoxymethylpenicillin 125mg/5ml oral solution | 100 | £8.65 |
| Phenoxymethylpenicillin 250mg/5ml oral solution | 100 | £8.47 |
| Pregabalin 75mg capsules | 56 | £2.03 |
| Quetiapine 25mg tablets | 60 | £1.38 |
| Rizatriptan 10mg orodispersible tablets sugar free | 3 | £10.45 |
| Ropinirole 500microgram tablets | 28 | £12.09 |
| Sodium chloride 0.9% nebuliser liquid 2.5ml unit dose ampoules | 20 | £9.50 |
| Topiramate 100mg tablets | 60 | £12.15 |
| Tramadol 37.5mg / Paracetamol 325mg tablets | 60 | £4.95 |
| Travoprost 40micrograms/ml / timolol 5mg/ml eye drops | 2.5 | £5.03 |
| Valaciclovir 500mg tablets | 10 | £17.57 |
| Warfarin 1mg tablets | 28 | £0.84 |
| Warfarin 5mg tablets | 28 | £1.58 |
*This price concession was withdrawn following a price adjustment under the price change mechanism. The new reimbursement price for August 2023 is £29.94. Click here for more information.
For the full list of price concessions granted for August 2023 including any rolled over from July, please visit our webpage: cpe.org.uk/priceconcessions
No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.
We encourage pharmacies to report any problems obtaining a Part VIII product at or below the stated Drug Tariff price, using the online feedback form on the Community Pharmacy England website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. We will investigate the extent of the problem and, if appropriate, discuss the issue with DHSC.
Please subscribe to our mailing list to receive email updates of any price concessions.
Further information on price concessions and FAQs about the process involved can be found on our website (cpe.org.uk/priceconcessions)
Improvements to the price concession system
Following significant concerns raised by pharmacies about the unsustainable level of prices imposed by DHSC in second half of 2022, it was agreed that an urgent review of the price concession setting system would take place.
Since this announcement, we have sent a strong and clear message back to Government that pharmacies cannot continue to subsidise the NHS medicines bill. Following the review of the concessionary price process, a package of measures has been developed to improve the system.
One of the solutions agreed between us and DHSC is that from 1st April 2023, all products granted a concessionary price will be classified as ‘Discount Not Deducted’ for the month(s) in which they are on concession.
Furthermore, from May 2023, DHSC has implemented a process to roll over prices to the following month for any concessions requested after the 23rd of the month provided these prices were agreed with us. We are also continuing to work with DHSC on how a ‘retrospective increased payment’ my apply, when appropriate. Further information regarding this concession ‘top-up’ mechanism will be issued once details are finalised.
